Loading…
Ganga Pharmaceuticals (BSE 539680)₹12.50+4.17%Pharmaceuticals
Ganga Pharmaceuticals is compared with the 10 closest in size in Pharmaceuticals (229 companies in the industry). It has a P/E of 78.1 against a peer median of 22.3, and ROCE of 2.9% against a peer median of 2.9%, and latest-quarter sales growth of 9.8% against a peer median of −8.8%. By market cap it is #7 of 11 in this set.
As of · Peer set: 10 closest in size in Pharmaceuticals
| Company | M-cap (₹ Cr) | P/E | ROCE % | ROE % | Debt / equity | Div. yield % | Sales (₹ Cr) | Net profit (₹ Cr) | Qtr sales growth % | Qtr profit growth % | Compare |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Desh Rakshak Aushdhalaya | 14 | 22.3 | 6.6 | 4.9 | 0.21 | 0.0 | 7 | 1 | −21.5 | −17.1 | vs BSE 539680 |
| Beryl Drugs | 13 | 31.1 | 7.2 | 4.3 | 0.25 | 0.0 | 19 | 0 | 4.8 | 292.9 | vs BSE 539680 |
| Unjha Formulations | 13 | 26.7 | 27.7 | 20.1 | 0.00 | 0.0 | 16 | 1 | −8.8 | −57.5 | vs BSE 539680 |
| ORTIN GLOBAL | 11 | — | −32.1 | −46.0 | 0.81 | 0.0 | 0 | −1 | 262.5 | — | vs BSE 539680 |
| Dipna Pharmachem | 11 | 4.2 | 8.1 | 5.3 | 0.21 | 0.0 | 129 | 3 | −87.2 | −62.7 | vs BSE 539680 |
| Adline Chem Lab | 9 | — | −933.4 | — | — | 0.0 | 0 | −0 | — | −145.5 | vs BSE 539680 |
| Ganga Pharmaceuticals | 7 | 78.1 | 2.9 | 1.3 | 0.13 | 0.0 | 3 | 0 | 9.8 | 40.0 | — |
| Brawn Biotech | 7 | 6.9 | 0.0 | 24.5 | 0.00 | 0.0 | 17 | 1 | −12.4 | — | vs BSE 539680 |
| Vivanza Biosciences | 6 | 14.5 | 6.0 | 9.4 | 2.33 | 0.0 | 116 | 0 | 3.9 | 75.0 | vs BSE 539680 |
| Decipher Labs | 6 | — | −16.6 | −14.2 | 0.02 | 0.0 | 14 | −3 | −16.8 | — | vs BSE 539680 |
| MPS Pharmaa | 4 | — | −13.1 | −176.9 | 107.04 | 0.0 | 0 | −1 | — | — | vs BSE 539680 |
| Peer median | 9 | 22.3 | 2.9 | 4.6 | 0.21 | 0.0 | 14 | 0 | −8.8 | −17.1 |
Listed companies closest to Ganga Pharmaceuticals in Pharmaceuticals include Desh Rakshak Aushdhalaya, Beryl Drugs, Unjha Formulations, ORTIN GLOBAL, Dipna Pharmachem, Adline Chem Lab, Brawn Biotech, Vivanza Biosciences.
Desh Rakshak Aushdhalaya, with a market cap of ₹13.97 Cr.
Ganga Pharmaceuticals trades at a P/E of 78.1; the median of its peer set is 22.3. A P/E above or below the median is a description, not a judgement on value.
Ganga Pharmaceuticals' return on capital employed is 2.9%, above the peer median of 2.9%.